Table 4.
Univariate and Multivariate Analysis of overall survival with Cox proportional hazards model
| Characteristics | Hazard ratio (95% CI) | P value |
|---|---|---|
| Univariate analysis | ||
| Adjuvant treatment | 0.075 (0.028–0.204) | 3.47e–7 |
| Post-operative complications | 4.119 (1.753–9.679) | 0.001 |
| Pre-operative KPS (KPS score ≥70 vs. KPS score <70) | 0.559 (0.301–1.040) | 0.066 |
| EOR (GTR+NTR vs. STR) | 0.540 (0.209–1.400) | 0.205 |
| MGMT * (methylated and partially methylated vs. unmethylated) | 0.694 (0.366–1.317) | 0.264 |
| Gender | 1.431 (0.762–2.690) | 0.265 |
| Image guidance technique (ioUS vs. ioMRI + ioUS) | 1.450 (0.712–2.954) | 0.306 |
| Pre-operative altered mental status | 1.290 (0.677–2.460) | 0.439 |
| Involvement of eloquent structures | 1.192 (0.621–2.289) | 0.598 |
| Pre-operative motor deficit | 1.175 (0.606–2.281) | 0.633 |
| Tumor volume | 0.998 (0.990–1.008) | 0.802 |
| Follow-Up KPS (KPS score ≥70 vs. KPS score <70) | 1.044 (0.495–2.203) | 0.910 |
| Multivariate analysis | ||
| EOR (GTR+NTR vs. STR) | 0.329 (0.121–0.896) | 0.030 |
| Post-operative complications | 3.620 (1.433–9.144) | 0.006 |
| Adjuvant treatment | 0.144 (0.057–0.362) | 3.80e–5 |
Bold values indicate statistical significance at the p < 0.05 level
*An independent univariate analysis was further performed to assess the impact of MGMT status on overall survival in patients who had MGMT status determined as “methylated” or “unmethylated” and received temozolomide treatment (n = 29), (P = 0.172, HR:0.550, 95% CI 0.233 – 1.30)
Abbreviations: KPS, Karnofski Performance Scale; ioUS, intraoperative ultrasonography; ioMRI, intraoperative magnetic resonance imaging; EOR, Extent of resection; GTR, gross total resection; NTR, near total resection; STR, subtotal resection